Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction.
about
Novel therapeutics for Alzheimer's disease: an updateMitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cellsCentral nervous system manifestations of mitochondrial disorders.Flavin adenine dinucleotide rescues the phenotype of frataxin deficiency.Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.Mitochondrial Drugs for Alzheimer Disease.Solid phase synthesis of mitochondrial triphenylphosphonium-vitamin E metabolite using a lysine linker for reversal of oxidative stress.Frontiers in Alzheimer's disease therapeutics.Avocado Oil Improves Mitochondrial Function and Decreases Oxidative Stress in Brain of Diabetic Rats.Mitochondrial Dysfunction during Brain Aging: Role of Oxidative Stress and Modulation by Antioxidant Supplementation.Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cellsTargeted drug delivery to mammalian mitochondria in living cells.The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelleGene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits.A mitochondria-targeted mass spectrometry probe to detect glyoxals: implications for diabetes.Mitochondria-targeted nutraceuticals in sports medicine: a new perspective.Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease.Delivery of antisense peptide nucleic acids (PNAs) to the cytosol by disulphide conjugation to a lipophilic cation.Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria.Long-distance apoptotic killing of cells is mediated by hydrogen peroxide in a mitochondrial ROS-dependent fashion.Mitochondrial-Based Therapeutics for the Treatment of Spinal Cord Injury: Mitochondrial Biogenesis as a Potential Pharmacological Target.
P2860
Q24620383-5D48AFE2-CEFF-4566-AEA8-17A0394D522CQ28474562-E9A60FFB-6B64-4DF6-B8C0-BF43D761E75FQ31058031-2E5DD1E7-513C-4C62-A3A6-C6DBD66C273CQ33527398-26C0EF77-4544-4195-9071-A5D8105AD3D5Q33913079-4FF4074F-C349-4086-8C2E-E229726A0200Q34016406-74E5F514-0BEB-459B-BFE7-B4D25F5E1953Q34558424-2BC4A5B5-5A0B-4F85-ACC8-961A0BCDF521Q35086876-F59D4929-B3E2-418A-9D05-ABF836E1FA3AQ35768737-65BB3A90-5554-4911-889F-C19FD1F95D1DQ35806752-510900EC-2C9D-42E2-BF3E-900159E92400Q36174209-8427FFDE-38C7-4357-80B4-C5A5D5B90380Q36316672-2E757203-9CA5-417B-A712-593DBA80866CQ37177530-0D902EE3-5854-47E9-ABB2-9B015C564386Q37999105-24A34A4B-4F7E-40E0-9AA4-277F94FF6C41Q38647043-8838A518-6437-4A24-85BA-B97892FC8EEBQ39010874-DE70BA9F-B172-4B58-93ED-8F70681E4642Q39351075-C4A0C307-3297-4E48-AC62-16134BED34EAQ40602204-6F8F5ECC-FA59-477C-808C-9CF9DE8195ADQ46438642-B20C2C70-3D90-45A7-A7D1-BF97D41A5AA2Q46525697-D7BA1953-AC3C-4ECF-B052-D9BF556BA53EQ47163634-E609225C-FE6F-4487-ABF4-E0A2A889455B
P2860
Development of lipophilic cations as therapies for disorders due to mitochondrial dysfunction.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of lipophilic cati ...... to mitochondrial dysfunction.
@ast
Development of lipophilic cati ...... to mitochondrial dysfunction.
@en
Development of lipophilic cati ...... to mitochondrial dysfunction.
@nl
type
label
Development of lipophilic cati ...... to mitochondrial dysfunction.
@ast
Development of lipophilic cati ...... to mitochondrial dysfunction.
@en
Development of lipophilic cati ...... to mitochondrial dysfunction.
@nl
prefLabel
Development of lipophilic cati ...... to mitochondrial dysfunction.
@ast
Development of lipophilic cati ...... to mitochondrial dysfunction.
@en
Development of lipophilic cati ...... to mitochondrial dysfunction.
@nl
P2860
P356
P1476
Development of lipophilic cati ...... to mitochondrial dysfunction.
@en
P2093
P2860
P304
P356
10.1517/14712598.1.5.753
P407
P577
2001-09-01T00:00:00Z